Literature DB >> 8283825

Exacerbation of airway hyperreactivity by (+/-)salbutamol in sensitized guinea pig.

K Hoshiko1, J Morley.   

Abstract

In guinea pigs passively sensitized to ovalbumin, sustained (6 days) subcutaneous infusion of (+/-)salbutamol (1 mg/kg/day) induced significant airway obstruction and heightened responsivity to airway spasmogens. Of these animals, a substantial proportion (78/235) were too responsive to injected spasmogens to permit infusion of ovalbumin or died following infusion of ovalbumin; yet there were few deaths (2/166) amongst the sensitized animals not exposed to (+/-)salbutamol. In comparison to the animals not exposed to (+/-)salbutamol, infusion of ovalbumin led to exaggerated responsivity of the airways to leukotriene C4, leukotriene E4, histamine, serotonin and acetylcholine, but not to prostaglandin F2 alpha or bradykinin. The capacity of sustained exposure to high doses of (+/-)salbutamol to induce airway hyperreactivity to allergic mediators may account for an association between asthma death and regular, excessive use of sympathomimetics.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8283825     DOI: 10.1254/jjp.63.159

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  10 in total

1.  S-albuterol exacerbates calcium responses to carbachol in airway smooth muscle cells.

Authors:  H Yamaguchi; J R McCullough
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

Review 2.  Anomalous effects of albuterol and other sympathomimetics in the guinea pig.

Authors:  J Morley
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

3.  Concerns regarding the current use of beta-agonists in the therapy of asthma.

Authors:  G Aberg; J Costello
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

4.  Effects of RS-albuterol on the development of antigen-mediated airway hyperreactivity in guinea pigs.

Authors:  A Jafarian; D A Handley; D F Biggs
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

Review 5.  Albuterol. A pharmaceutical chemistry review of R-, S-, and RS-albuterol.

Authors:  R P Bakale; S A Wald; H T Butler; Y Gao; Y Hong; X Nie; C M Zepp
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

6.  Effects of albuterol enantiomers on in vitro bronchial reactivity.

Authors:  F Johansson; I Rydberg; G Aberg; R G Andersson
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

7.  Sympathomimetics and airway hyperreactivity.

Authors:  J Morley
Journal:  Thorax       Date:  1994-11       Impact factor: 9.139

8.  Occupational asthma in salbutamol process workers.

Authors:  R M Agius; A G Davison; E R Hawkins; A J Newman Taylor
Journal:  Occup Environ Med       Date:  1994-06       Impact factor: 4.402

9.  The temporal hormesis of drug therapies.

Authors:  Noor Dudekula; Vikas Arora; Zsuzsanna Callaerts-Vegh; Richard A Bond
Journal:  Dose Response       Date:  2006-05-01       Impact factor: 2.658

10.  Albuterol enantiomer levels, lung function and QTc interval in patients with acute severe asthma and COPD in the emergency department.

Authors:  Kwang Choon Yee; Glenn A Jacobson; Richard Wood-Baker; E Haydn Walters
Journal:  Int J Emerg Med       Date:  2011-06-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.